The Therapeutic Goods Administration (TGA) is reminding advertisers that first aid creams containing bufexamac cannot be advertised to Australian consumers from 18 September 2020.nnThe TGA issued a safety alert for first aid creams containing bufexamac on 8 September 2020 advising of the risk of serious skin reactions (allergic contact dermatitis). The safety alert also advised that 12 topical first aid creams that contain the active ingredient bufexamac, under various brand names, will be cancelled from the Australian Register of Therapeutic Goods (ARTG), effective on 18 September 2020.